High dose induction therapy with interferon alpha followed by combination therapy for naive hepatitis C patients - Results of a multicenter randomized controlled study.

被引：0
|
作者：
Kaiser, S
Kreysel, C
Zeitz, M
Schneider, W
Gregor, M
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Univ Homburg, D-6650 Homburg, Germany
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1608
引用
收藏
页码：561A / 561A
页数：1
相关论文
共 50 条
  • [1] High dose induction therapy with interferon alpha followed by combination therapy for naive hepatitis C patients - Results of a multicenter randomized controlled study.
    Kaiser, S
    Kreysel, C
    Zeitz, M
    Schneider, W
    Gregor, M
    GASTROENTEROLOGY, 2000, 118 (04) : A951 - A951
  • [2] High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive hepatitis C patients
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 137 - 137
  • [3] High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive hepatitis C patients
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    GASTROENTEROLOGY, 2001, 120 (05) : A383 - A383
  • [4] High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive hepatitis C patients.
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    HEPATOLOGY, 2001, 34 (04) : 581A - 581A
  • [5] High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive patients with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Gregor, M
    HEPATOLOGY, 2000, 32 (04) : 561A - 561A
  • [6] High dose induction interferon therapy followed by combination therapy with ribavirin for hepatitis C non-responders.
    Kaiser, S
    Kreysel, C
    Zeitz, M
    Schneider, W
    Domschke, W
    Menzel, M
    Gregor, M
    GASTROENTEROLOGY, 2000, 118 (04) : A950 - A950
  • [7] A RCT of high-dose IFN induction followed by combination therapy with ribavirin in naive patients with chronic hepatitis C.
    Vaccaro, A
    Di Marco, V
    Ferraro, D
    Parisi, P
    Cappello, M
    Cino, N
    Di Stefano, R
    Almasio, PL
    Craxi, A
    HEPATOLOGY, 2000, 32 (04) : 363A - 363A
  • [8] High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis C
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 113 - 114
  • [9] Combination therapy with low dose interferon and ribavirin in naive patients with hepatitis C.
    Martin, A
    Canchis, PW
    Tamburro, CH
    Fortwengler, P
    Cecil, B
    Cox, A
    Adler, E
    Miller, B
    Chene, B
    Hiser, M
    HEPATOLOGY, 1999, 30 (04) : 620A - 620A
  • [10] Comparison of daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Kadakia, SC
    Cantu, N
    Jeffries, MA
    Schutz, SM
    Matossian, H
    Jolley, JJ
    Sheinbaum, AJ
    Meadows, JG
    GASTROENTEROLOGY, 2000, 118 (04) : A1461 - A1461
12345